Calcein as a fluorescent iron chemosensor for the determination of low molecular weight iron in biological fluids

BioMetals

Volumn 16, Issue 2, 2003, Pages 285-293

  Ali, Aktar ^a   Zhang, Qi ^a   Dai, Jisen ^a   Huang, Xi ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcein; Iron; Iron overload; Low molecular weight iron; Non transferrin bound iron

Indexed keywords

CALCEIN; FERRIC CITRATE; FERRIC SULFATE; IRON; TRANSFERRIN;

ARTICLE; CELL CULTURE; FLUORESCENCE; HEPATOMA CELL; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; IRON OVERLOAD; MOLECULAR WEIGHT; SENSOR;

BODY FLUIDS; CELL LINE; CITRIC ACID; COAL; DEFEROXAMINE; DUST; FLUORESCEINS; FLUORESCENCE; FLUORESCENT DYES; HUMANS; IRON; IRON CHELATING AGENTS; MOLECULAR WEIGHT; TRANSFERRIN;

EID: 0037409871     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020642808437     Document Type: Article

References (30)

1. Addess KJ, Basilion JP, Klausner RD, Rouault TA, Pardi A. 1997 Structure and dynamics of the iron responsive element RNA: implications for binding of the RNA by iron regulatory binding proteins. J Mol Biol 274, 72-83.
2. Aisen P, Wessling-Resnick M, Leibold EA. 1999 Iron metabolism. Curr Opin Chem Biol 3, 200-206.
3. Attfield MD, Morring K. 1992 An investigation into the relationship between coal workers' pneumoconiosis and dust exposure in U.S. coal miners. Am Ind Hyg Assoc J 53, 486-492.
4. Breuer W, Epsztejn S, Cabantchik ZI. 1996 Dynamics of the cytosolic chelatable iron pool of K562 cells. FEBS Lett 382, 304-308.
5. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. 2000 Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy. Transfus Sci 23, 241-242.
6. Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C, Cabantchik ZI. 2000 The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 95, 2975-2982.
7. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. 2001 Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 97, 792-798.
8. Cabantchik ZI, Glickstein H, Milgram P, Breuer W. 1996 A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal Biochem 233, 221-227.
9. Comporti M, Signorini C, Buonocore G, Ciccoli L. 2002 Iron release, oxidative stress and erythrocyte ageing(2) (3). Free Radic Biol Med 32, 568-576.
10. Epsztejn S, Kakhlon O, Glickstein H, Breuer W, Cabantchik I. 1997 Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem 248, 31-40.
11. Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC. 1999 Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 273, 212-220.
12. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. 1989 Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 264, 4417-4422.
13. Huang X, Kitahara J, Zhitkovich A, Dowjat K, Costa M. 1995 Heterochromatic proteins specifically enhance nickel-induced 8-oxo-dG formation. Carcinogenesis 16, 1753-1759.
14. 2+ content: possible role in coal workers' pneumoconiosis. Chem Res Toxicol 11, 722-729.
15. Huang X, Dai J, Fournier J, Ali AM, Zhang Q, Frenkel K. 2002 Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells. Free Radic Biol Med 32, 84-92.
16. Jacobs A. 1977 Low molecular weight intracellular iron transport compounds. Blood 50, 433-439.
17. Kang JO, Jones C, Brothwell B. 1998 Toxicity associated with iron overload found in hemochromatosis: possible mechanism in a rat model. Clin Lab Sci 11, 350-354.
18. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM. 1991 Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci USA 88, 4946-4950.
19. Morgan WKC, Burgess DB, Jacobson G, O'Brien RJ, Pendergrass E, Reger RB, Shoub EP. 1973 The prevalence of coal workers' pneumoconiosis in US coal miners. Arch Environ Health 27, 221-230.
20. Petrat F, Rauen U, de Groot H. 1999 Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology 29, 1171-1179.
21. Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S. 1996 Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88, 705-713.
22. Selby JV, Friedman GD. 1988 Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer 41, 677-682.
23. Stevens RG, Jones DY, Micozzi MS, Taylor PR. 1988 Body iron stores and the risk of cancer. N Engl J Med 319, 1047-1052.
24. Theil EC. 1990 Regulation of ferritin and transferrin receptor mRNAs. J Biol Chem 265, 4771-4774.
25. Theil EC. 1998 The iron responsive element (IRE) family of mRNA regulators. Regulation of iron transport and uptake compared in animals, plants, and microorganisms. Met Ions Biol Syst 35, 403-434.
26. Thomas F, Serratrice G, Beguin C, Aman ES, Pierre JL, Fontecave M, Laulhere JP. 1999 Calcein as a fluorescent probe for ferric iron. Application to iron nutrition in plant cells. J Biol Chem 274, 13375-13383.
27. Toyokuni S. 1996 Iron-induced carcinogenesis: The role of redox regulation. Free Radic Biol Med 20, 553-566.
28. Welch KD, Davis TZ, Van Eden ME, Aust SD. 2002 Deleterious iron-mediated oxidation of biomolecules(1) (6). Free Radic Biol Med 32, 577-583.
29. Wurzelmann JI, Silver A, Schreinemachers DM, Sandler RS, Everson RB. 1996 Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomark Prev 5, 503-507.
30. Zhang Q, Dai JS, Ali AM, Chen LC, Huang X. 2002 Roles of bioavailable iron and calcium in coal dust-induced oxidative stress: possible implications in coal workers' lung disease. Free Radical Res 36, 285-294.